Healthpeak Properties

1) Strategy & Leadership
- Healthpeak Properties has adopted a "winning mindset" to navigate challenging market conditions, emphasizing the importance of strategic actions taken during the downturn, including a $5 billion merger and a $1 billion IPO.
- The company is rolling out an "agentic operating platform" to enhance operational efficiency and tenant relationships.
- Partnerships with major investors like Blackstone and Brookfield are expected to provide alternative equity capital and allow Healthpeak to maintain control over strategic properties.

2) Financial & Segment Results
- FFO as adjusted for Q2 2026 was reported at $0.46 per share.
- The company achieved a net debt-to-EBITDA ratio of 4.7x, with leverage below 5x, indicating a strong balance sheet.
- In the outpatient medical segment, Healthpeak executed 1.2 million square feet of leases, achieving 5% cash re-leasing spreads and a total occupancy increase to 90.7%.
- The life science segment saw a significant uptick in public capital raising, with year-to-date FDA approvals exceeding the 5-year trend.

3) Operational Plans & Growth Opportunities
- Healthpeak plans to capitalize on the life science sector through acquisitions, shifting from a development focus to an acquisition strategy.
- The company has a robust leasing pipeline, with 204,000 square feet of leases executed since July and 882,000 square feet under LOI.
- In Senior Housing, Healthpeak's ownership interest in Janus Living has grown to 74%, with a 45% revenue growth and 34% adjusted EBITDA growth reported for the segment.

4) Guidance & Outlook
- Healthpeak raised its FFO guidance for the year to a range of $1.73 to $1.77 per share, driven by improved same-store NOI projections.
- The company anticipates continued growth in total occupancy across its segments, particularly in outpatient medical and life sciences, with modest improvements expected through year-end.
- Healthpeak is poised to leverage its strong balance sheet for future investments while remaining patient to ensure impactful capital deployment.

5) Problems / Headwinds
- The company noted that while the leasing environment is improving, there remains caution among tenants, leading to longer timelines for lease executions.
- The Boston lab market is currently facing challenges due to a supply overhang, although Healthpeak's properties are performing better than the overall market.

Bottom line: Healthpeak Properties is strategically positioned for growth with a strong balance sheet and a focus on operational efficiency, particularly in outpatient medical and life sciences. The company is optimistic about future occupancy improvements and capitalizing on acquisition opportunities, making it an attractive prospect for shareholders.